monoclonal antibody against human cyclin d1 protein (Santa Cruz Biotechnology)
Structured Review

Monoclonal Antibody Against Human Cyclin D1 Protein, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 98/100, based on 7207 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/monoclonal antibody against human cyclin d1 protein/product/Santa Cruz Biotechnology
Average 98 stars, based on 7207 article reviews
Images
1) Product Images from "Evaluation of Cyclin D1 protein and its association with the clinicopathological characteristics and prognosis of lung cancer: A retrospective study from Southern Kerala, India"
Article Title: Evaluation of Cyclin D1 protein and its association with the clinicopathological characteristics and prognosis of lung cancer: A retrospective study from Southern Kerala, India
Journal: Lung India : Official Organ of Indian Chest Society
doi: 10.4103/lungindia.lungindia_257_24
Figure Legend Snippet: Clinical and pathological characteristics
Techniques Used: Expressing
Figure Legend Snippet: Immunohistochemistry images of cyclin D1 expression in lung cancer tissues and normal tissues. (a). LUAD, (b). LUSC, (c). NSCLC, (d). PDC, (e). and NMC, (f). Graphical representation of individual cyclin D1 H scores for each histology type
Techniques Used: Immunohistochemistry, Expressing
Figure Legend Snippet: Clinicopathological characteristics and cyclin D1 expression
Techniques Used:
Figure Legend Snippet: Relationship between the expression of cyclin D1 and the prognosis of lung cancer
Techniques Used: Expressing
Figure Legend Snippet: Kaplan–Meier survival curves at 24 months based on cyclin D1 expression status
Techniques Used: Expressing